General Mills (GIS) Q4 2026 earnings review
Massive Impairments Cloud Q4; FY27 Points to Further Contraction
General Mills reported a catastrophic $2.1B operating loss in Q4 driven by $1.75B in Pet segment impairments and a $1.0B charge for the Brazil divestiture. While management highlights Q4 adjusted EPS of $0.95 (+27% CC), this was heavily inflated by a 53rd week and trade timing shifts. Stripping away the noise, FY26 organic sales fell 2% and adjusted operating profit sank 16%. Looking ahead, the 'Remarkability' reinvestment strategy is failing to spark a true turnaround: FY27 guidance calls for negative-to-flat organic sales and another 8-13% drop in adjusted operating profit, extending the company's earnings recession into a third year.
🐂 Bull Case
Management announced a massive $3 billion cumulative cost savings target by 2030 (via Holistic Margin Management and global transformation), with $750 million slated for FY27 to fund brand investments.
Adjusted gross margin expanded 150 bps in Q4 to 34.2%, showing that net price realization and cost controls are working despite overall volume challenges.
🐻 Bear Case
The $1.75B non-cash impairment of the North America Pet reporting unit and Nudges/True Chews brands destroys the prior narrative that the Pet business was 'stabilizing.' Organic sales for Pet declined 3% in Q4.
Despite heavily investing in price and 'Remarkability' throughout FY26, FY27 organic sales guidance (-1.5% to +0.5%) shows no imminent return to meaningful top-line growth.
⚖️ Verdict: 🔴
Bearish. The sheer scale of the Pet and Brazil write-offs ($2.8B combined) exposes severe capital misallocation, and the FY27 outlook confirms the turnaround is taking much longer and costing far more than anticipated.
Key Themes
Pet Segment Collapse Contradicts Positive Narrative
For quarters, management has pitched the stabilization of the Pet segment and the success of the 'Love Made Fresh' launch. Q4 results aggressively contradict this: the company took a $1.5B goodwill impairment on the NA Pet unit and $250M on Pet brands (Nudges, True Chews). Furthermore, Q4 Pet organic sales fell 3% despite a 7-point benefit from the 53rd week on reported metrics. The underlying asset value has severely deteriorated.
$3 Billion Cost Savings Initiative
To offset sluggish organic sales and fund marketing, General Mills is leaning heavily on cost reduction. The company unveiled a target of $3 billion in cumulative savings by FY30. $2 billion will come from the ongoing Holistic Margin Management (HMM) program (targeting ~4% of COGS annually), while $1 billion will stem from a new global transformation initiative (supply chain redesign, process streamlining). FY27 expects to capture $750 million of this total.
Macro Pressures on the Consumer
Management continues to cite weaker consumer sentiment and significant volatility weighing on category volume. The 'cost of volume' remains high as consumers increasingly shift purchases toward promotions, making it difficult for the company to achieve positive price/mix without sacrificing volume, particularly in the core North America Retail segment.
Innovation and 'Remarkability' Framework
With base price adjustments complete, FY27 strategy hinges entirely on product innovation. The company is leaning into better-for-you benefits (protein, fiber) and bold flavors. Cheerios Protein is already tracking toward a $100 million brand, and new product contribution is expected to remain above 25% of net sales.
Exiting Brazil at a Major Loss
General Mills announced the sale of its Brazil business (Yoki and Kitano brands) to Café Três Corações. The strategic rationale is sound—exiting an under-scaled, low-margin region to focus on global platforms. However, the financial execution is painful, resulting in a $1.03 billion non-cash pre-tax valuation loss to mark the business down to its estimated net proceeds.
Other KPIs
Up 7% YoY. However, this growth is highly distorted. Favorable trade expense timing provided a massive 9-point benefit to operating profit growth in the quarter. Strip that away, and underlying OP was negative due to lower organic volume and input cost inflation.
Decelerating. This implies a Free Cash Flow conversion rate of 85% of adjusted after-tax earnings, missing the company's prior guidance target of 'at least 95%'. Capital investments fell to $540M from $625M last year, but weaker operating cash flows pressured the final metric.
Guidance
Stable but stagnant. The midpoint (-0.5%) suggests General Mills will fail to return to organic growth in FY27, lapping a year (FY26) that already saw a 2% decline. The 'Remarkability' framework is arresting the plunge, but not reversing it.
Decelerating. Management blames a 9-point headwind from lapping the 53rd week, corporate incentive normalization, and divestiture impacts. Even so, the base business is not generating enough operating leverage to outgrow these structural drags.
Decelerating. The midpoint of $3.10 represents a ~12.6% decline from FY26's $3.55. This marks the third consecutive year of falling adjusted EPS, down significantly from the peak of $4.52 in FY24.
Accelerating slightly vs FY26 actuals (85%), aligning with historical targets. This will be critical to sustaining the $0.61 quarterly dividend and resuming meaningful share repurchases, which slowed to $500M in FY26.
Key Questions
Pet Segment Visibility
Given the $1.75B in impairments in the Pet segment and the 3% drop in Q4 organic sales, how should investors underwrite the success of 'Love Made Fresh' and the core Wilderness brand going forward? Were past models too optimistic?
Cost Savings Execution
Of the $3 billion in cost savings planned through 2030, $1 billion relies on 'global transformation'. Can you provide specific examples of supply chain or process redesigns that give you confidence in hitting the $750M target for FY27?
Organic Volume Recovery
If targeted price investments are largely complete, and FY27 organic sales are guided to be roughly flat, when does management actually expect a return to positive, volume-driven organic growth?